Bahrain Mirror: The health ministry withdrew from all its hospitals and health centers Apo-Ranitidine drug, from Apotex Company.
This measure comes after the National Health Regulatory Authority announced the withdrawal of all forms of Zantac and Apo-Ranitidine from the market as they contain some carcinogenic impurities of NDMA according to the results of laboratory tests.